However, customers employ NGS for a broad range of applications, and there is no ideal product for NGS informatics. Therefore, customers may struggle to identify the appropriate tools for their needs. The wide variety of free public domain and commercial tools provided by the 100 plus competitors in this market has also led to low barriers to entry, ever-intensifying competition, and commoditization in certain product segments.
Moreover, given the array of public and open source software available along with readily accessible internal bioinformatics resources, NGS users are often hesitant to make additional investments in commercial informatics tools. Therefore, beyond the challenges of commoditization and standardization, suppliers must convince NGS users their commercial tools are better than free ones.
"As the market matures and informatics prices fall, competitors will rely not just on the expanding volume of users and NGS data developed but also on the high-value interpretation sector of the market to sustain profits globally," opined Bird. "Suppliers that can develop high-value, simple and streamlined turnkey solutions will find success."
Global Next Generation Sequencing Informatics Market is part of the Life Sciences Growth Partnership Service program. Frost & Sullivan's related research services include: Global Mass Spectrometry Markets, Global microRNA Tools and Services Markets, U.S. qPCR and dPCR Instrumentation Markets, and Global Quantitative and dPCR Instrumentation and Consumables Purchasing Trends. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.
Connect with us on social media, including Twitter,
|SOURCE Frost & Sullivan|
Copyright©2012 PR Newswire.
All rights reserved